Skip to content

Supplier News

Ada Health and Pfizer collaborate

Ada Health and Pfizer collaborate

Ada Health (Ada) has teamed with Pfizer to launch its first digital condition-based care journey, designed to help people understand if they meet current criteria for progression to severe COVID-19 and connect with a health care provider for evaluation of their COVID-19 symptoms and treatment option

Bud Light returns to Super Bowl with new campaign

Bud Light returns to Super Bowl with new campaign

Bud Light is back on the Super Bowl stage – and showing up in style – with a brand-new campaign and the debut of its latest Super Bowl commercial, “Hold,” featuring Hollywood it-couple, Miles and Keleigh Teller. “Hold” signals a new era for the Bud Light brand as it looks to reach fans 21+ in

Mesmerize adds Express Rx pharmacies to network

Mesmerize adds Express Rx pharmacies to network

Mesmerize, a prominent out-of-home media company specializing in patient education at the point of care, announced the expansion of its pharmacy network to include Express Rx pharmacies. Express Rx offers high-quality, personalized service at their pharmacies within the Southeast U.S.

Camber launches generic Namenda

Camber launches generic Namenda

Camber Pharmaceuticals has added memantine HCl Tablets to its portfolio. The generic version of Namenda is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine HCl tablets are available in 5 and 10 mg strengths and supplied in 60-count bottles.

Upsher-Smith expands fluoxetine product family

Upsher-Smith expands fluoxetine product family

MAPLE GROVE, Minn. – Upsher-Smith announced that it has expanded its fluoxetine product family with the launch of Fluoxetine Oral Solution, USP, 20 mg/5 mL. Upsher-Smith’s product is a generic version of the product, Prozac (fluoxetine) Oral Solution. The fluoxetine oral solution market had U.S.

Sales of herbal immune supplements rise

Sales of herbal immune supplements rise

ST. PETERSBURG, Fla. – During the final quarter of 2022, even as the U.S. grappled with a “tripledemic” of flu, RSV and COVID-19, unit sales of vitamins and health supplements declined over the prior year while average unit prices rose, according to shopper intelligence leader Catalina.